Thus, a recent study based on the analysis of a very large number of ovarian cancer patients (more than 5500 patients with various types of ovarian cancer) provided clear evidence that HGSOC patients displaying a high number of intra-tumor CD8+ T lymphocytes have a longer overall survival [89]. The gene discussed is CD8A; the disease is ovarian cancer.